天美传媒

Mara Aspinall is an expert in biomedical diagnostics, biomedicine and medical diagnostic devices.

She is a professor of practice in the College of Health Solutions and the co-founder of the Biomedical Diagnostics program within the college.

Throughout her career, Aspinall has spearheaded initiatives to educate payers and policymakers on genomics and personalized medicine.

In addition to her position at ASU, Aspinall is the co-founder and managing director of BlueStone Venture Partners and the managing director of Health Catalysts Group.

, is a gynecologic oncologist who specializes in the surgical management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive surgery, chemotherapy and novel drugs.
Eskander is also experienced in clinical trial development and aims to provide individuals with access to innovative medicines during their treatment. He is a member of  and the clinical trials office director for oncology.
As an assistant professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California San Diego, Eskander instructs medical students, residents and fellows. His research focuses on immunotherapy, targeted therapies for treating clear cell and endometrioid ovarian cancer, quality of life in cancer patients, and end-of-life care.
Eskander speaks Arabic and Spanish fluently.